Duchenne Muscular Dystrophy News and Research

RSS
Duchenne muscular dystrophy (DMD) is a progressive muscle disorder that causes the loss of both muscle function and independence. DMD is perhaps the most prevalent of the muscular dystrophies and is the most common lethal genetic disorder diagnosed during childhood today. Each year, approximately 20,000 children worldwide are born with DMD (one of every 3,500 male children).
Using motion capture technology and AI to monitor the progression of movement disorders

Using motion capture technology and AI to monitor the progression of movement disorders

Gene editing could offer a promising solution for treating patients after a heart attack

Gene editing could offer a promising solution for treating patients after a heart attack

Mutations responsible for common inherited heart condition corrected using CRISPR-Cas9 therapy

Mutations responsible for common inherited heart condition corrected using CRISPR-Cas9 therapy

Researchers receive $9 million grant to study how ‘jumping genes’ influence Alzheimer's disease

Researchers receive $9 million grant to study how ‘jumping genes’ influence Alzheimer's disease

New discovery changes the understanding of Duchenne muscular dystrophy

New discovery changes the understanding of Duchenne muscular dystrophy

Experimental drug prolongs survival, improves muscle function in mice severe Duchenne muscular dystrophy

Experimental drug prolongs survival, improves muscle function in mice severe Duchenne muscular dystrophy

Researchers receive $1.2 million Keck Foundation grant to find molecules for targeting the 'undruggable proteome'

Researchers receive $1.2 million Keck Foundation grant to find molecules for targeting the 'undruggable proteome'

Cancer drug helped delay progression of Duchenne muscular dystrophy in mice

Cancer drug helped delay progression of Duchenne muscular dystrophy in mice

Existing cancer drug shows promise for treating patients with muscular dystrophy

Existing cancer drug shows promise for treating patients with muscular dystrophy

U-M researchers reveal how a mutated protein acts as risk factor in Parkinson’s disease

U-M researchers reveal how a mutated protein acts as risk factor in Parkinson’s disease

The promise of RNA medicine is targeted and personalized

The promise of RNA medicine is targeted and personalized

Study supports daily steroid doses for children with Duchenne muscular dystrophy

Study supports daily steroid doses for children with Duchenne muscular dystrophy

Lab grown, self-renewing muscle stem cells can repair muscle tissue damage in mice

Lab grown, self-renewing muscle stem cells can repair muscle tissue damage in mice

Using CRISPR/Cas to develop biosafety materials

Using CRISPR/Cas to develop biosafety materials

Reactivating Piezo1 protein could help repair broken down, dystrophic muscles

Reactivating Piezo1 protein could help repair broken down, dystrophic muscles

Cellular therapy offers promise for patients with Duchenne muscular dystrophy, trial shows

Cellular therapy offers promise for patients with Duchenne muscular dystrophy, trial shows

Glucocorticoid steroids improve muscle performance through distinct, sex-specific molecular pathways

Glucocorticoid steroids improve muscle performance through distinct, sex-specific molecular pathways

Inside the tactical tug of war over the controversial Alzheimer’s drug

Inside the tactical tug of war over the controversial Alzheimer’s drug

Study reveals link between muscular dystrophy and sphingolipids

Study reveals link between muscular dystrophy and sphingolipids

Novel gene therapy for diseased muscle fiber repair

Novel gene therapy for diseased muscle fiber repair